Haemorrhagic condition in open heart surgery. Hemorrhagic condition, unspecified
Conditions
Interventions
Intervention 1: Intervention group: transamine injection alone 50Mg/kg bolus before surgical incision (Iran. Co Pharmaceutical Tamin Caspian®, Tranexip ) Half an hour before the surgery, the patien
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age between 30-80 years EF>30% BMI<26 written informed consent no history of drug sensitivity first heart surgery no history of disorders and coagulation factors hemoglobin more than 10 gr/dl
Exclusion criteria
Exclusion criteria: Dissatisfaction and willingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of blood loss during and after surgery. Timepoint: at Hour 0, 2, 4, 6, 8, 10, 12. Method of measurement: visual estimation of blood loss in bottles. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring length of stay in ICU. Timepoint: Days of hospitalization in the ICU. Method of measurement: number of days.;Measuring length of stay in hospital. Timepoint: Days of hospitalization in hospital. Method of measurement: number of days.;Measuring the amount of hemoglobin drop. Timepoint: after surgery. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFozieh Bakhsha
Gorgan University of Medical Sciences
Outcome results
None listed